Nanoscale doctors curing the body from within sounds like science fiction, but for Japanese research centre COINS, it’s a serious goal.
Category: biotech/medical
This is the FOURTH PART of the interview with Harold Katcher in Modern Healthspan YouTube channel.
Dr. Harold Katcher is a professor of Biology at the University of Maryland. He has been a pioneer in the field of cancer research, in the development of modern aspects of gene hunting and sequencing. He carries expertise in bioinformatics, chronobiology, and biotechnology. Dr. Katcher is currently working in the capacity of Chief Technical Officer at Nugenics Research exploring rejuvenation treatments in mammals.
In May 2020 there was a paper published on biorxiv about the rejuvenation of rats by over 50%. We did a review of the paper which you can find linked to above. In this interview series we talk with Dr. Harold Katcher, one of the main authors of the paper about the experiment, the steps to get validation, commercialization and how the results fit into his theories of aging.
In this video Dr. Katcher explains his theories on what causes aging, which he believes is a process that is programmed into us and is therefore malleable. I find his theories very interesting and compelling.
Dr. Katcher’s 2015 paper on the theory of aging is here:
Towards an evidence-based model of aging.
https://pubmed.ncbi.nlm.nih.gov/26054348/
The paper on plasma exchange can be found here https://www.biorxiv.org/content/10.1101/2020.05.07.082917v1.full.
If you would like to support our channel, we’d love a coffee…thank you!
https://www.buymeacoffee.com/mhealthspan.
#HaroldKatcher #HorvathClock #ReverseAging
A new type of quantum holography which uses entangled photons to overcome the limitations of conventional holographic approaches could lead to improved medical imaging and speed the advance of quantum information science.
There’s a mini second genome inside your cells, but no one could figure out how to edit it — until now.
Human-Autonomy Interaction, Collaboration and Trust — Dr. Julie Marble, JHU Applied Physics Laboratory (APL)
Dr. Julie Marble is a senior scientist at the Johns Hopkins University Applied Physics Laboratory (JHUAPL) leading research in human-autonomy interaction, collaboration and trust.
Dr. Marble earned her PhD in Human Factors/Cognitive Psychology from Purdue University. After graduating from Purdue University, she joined the Idaho National Laboratory (INL), one of the national laboratories of the United States Department of Energy involved in nuclear research, first in the Human Factors group and then the Human and Robotic Systems group.
Following INL, she joined Sentient Corporation, where as CEO she led a DARPA Broad Agency Announcement BAA on Neuro-Technology for Intelligence Analysts and led research on to develop an intelligent decision aid to perform just-in-time maintenance on Navy helicopters.
Dr. Marble then worked as a Senior Scientist at the US Nuclear Regulatory Commission leading international and US studies on Human-Reliability Analysis methods in this vital domain and related to this, she is internationally recognized for her work, and is co-author of the SPAR-H method (Standardized Plant Analysis Risk Human Reliability Analysis), the most commonly used method of human reliability analysis in the US. She is also co-developer of the Cultural Affective Model, which integrates cultural impacts into human reliability in order to predict operator behavior.
Dr. Marble then joined the Office of Naval Research as a Program Officer, where she established the Hybrid Human Systems and the Human Factors of Cyber Security programs.
She was appointed to the NATO Collaborative Science Office, Science and Technology Office, Human Factors and Medicine Research Task Group on Human Factors and Cyber Security in 2014, and joined JHUAPL in 2015.
We can immediately supersede the Mojo Vision approach for retinal projection, with an interim projection system using metalenses. The Mojo Lens approach is to try to put everything, including the television screen, projection method and energy source onto one contact lens. With recent breakthroughs in scaling up the size of metalenses, an approach utilizing a combination of a contact metalens and a small pair of glasses can be utilized. This is emphatically not the Google Glass approach, which did not use modern metalenses. The system would work as follows:
1)Thin TV cameras are mounted on both sides of a pair of wearable glasses.
2)The images from these cameras are projected via projection metalenses in a narrow beam to the center of the pupils.
3)A contact lens with a tiny metalens mounted in the center, directly over the pupil, projects this projected beam outwards, through the pupil, onto the full width of the curved retina.
The end result would be a 360 degree, full panorama image. This image can either be a high resolution real time vision of the wearer’s surroundings, or can be a projection of a movie, or augmented reality superimposed on the normal field of vision. It can inherently be full-color 3D. Of course such a system will be complemented with ear phones. Modern hearing aids are already so small they can barely be seen, and have batteries that last a week. A pair of ear phones will also allow full 3D sound and also will be the audible complement of augmented vision.
Cameras in cell phones using traditional lenses are already very thin, and even they could be used for an experimental system of this type, but the metalens cameras will make this drastically thinner. The projection lens system must work in combination with the lens over the pupil. This also means that when the glasses are removed, the contact lens must also be removed, or the vision will be distorted.
The end result will be a pair of glasses, not quite as thin as an ordinary pair of glasses, but still very thin and comfortable. Instead of trying to mount the power source in the contact lens, like Mojo Vision is trying to do, a small battery would be mounted in the glasses. Mojo Vision is probably going to have to do something similar for the power source: put the battery in a small pair of glasses that projects the energy onto its contact lens.
This also solves the problem of the exit pupil limitations from binoculars. The entire light of the objective metalenses is projected through the pupil, since it is using a narrow beam projection method. The special lens mounted on the contact lens, will be tailored to work with this system. The included photograph is of underwater, single-separated googles, which gives an idea of what this might look like.
The U.S. military routinely deploys throughout the world where warfighters can potentially be exposed to regional endemic diseases as well as chemical, biological, radiological, or nuclear (CBRN) threats. Rapid access to medical countermeasures (MCMs) against these threats is critical to protect Defense Department (DoD) personnel and local populations; however, manufacturing, stockpiling, and distribution issues remain.
A pacesetting institution, the Icahn School of Medicine at Mount Sinai is opening a psychedelic research center focusing on MDMA and trauma.
It’s too early to call it a miracle cure, but if the conclusions from a recent Phase 1 trial for a new drug called EXO-C24 are backed up in subsequent trials, we might have the first true breakthrough therapy for COVID-19. That’s in addition to coronavirus vaccines, of course, which will help prevent severe COVID-19 cases and deaths, and even reduce the spread of the illness. But while vaccines can give the immune system a heads-up to the threat it might have to deal with — the real virus — they have a few limitations. First of all, they don’t work on infected people. Secondly, vaccine supply is still limited and vaccinations aren’t available to anybody who might want one. Then there’s the threat of coronavirus mutations that might reduce vaccines’ effect on the virus and extend the pandemic.
O,.o.
As the opioid epidemic raged on with an even greater force during COVID-19, the Scripps Research laboratory of chemist Kim Janda, Ph.D., has been working on new therapeutic interventions that may be able to prevent the bulk of deaths from opioid overdose.